Nephros named Andrew Astor as chief financial officer. Astor previously served as managing director at Synechron. Prior to that role, he was a vice president at Asurion.
Relief Therapeutics has a new interim CEO, Gael Hedou, the company’s former COO. Raffaele Petrone has resigned from his role as CEO and Timothy Snyder will be relinquishing his duties as chief financial officer on Aug. 31, 2017.
Edge Therapeutics recruited Alyssa Wyant as senior vice president for regulatory affairs. Most recently, Wyant served as vice president of global regulatory affairs at PTC Therapeutics.
Harpoon Medical hired Laura Brenton as vice present of clinical affairs. She brings more than 25 years of clinical research experience, with the last decade at Harpoon.